Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group.
Mirthe Jasmijn Klein HaneveldMark J C van TreijenCarolina R C PietermanOlaf M DekkersAnnenienke van de VenWouter W de HerderWouter T ZandeeMadeleine L DrentPeter H BisschopBas HavekesMenno R VriensAnnemarie A Verrijn StuartGerlof Dirk ValkRachel S van LeeuwaardePublished in: The Journal of clinical endocrinology and metabolism (2021)
Analyses from this population-based cohort indicate that start of surveillance for NF-pNETs with pancreatic imaging at age 13 to 14 years is justified. The psychological and medical burden of screening at a young age should be considered.